Question number,Question,Retrieved FileName,Chunk Text,Page Number,Position,Similarity
1,Does early administration of neuromuscular blocking agents increases the ventilator free days?,FMWSCPARDS.pdf," mortality to FACTT Conservative. FACTT Conservative has improved ventilator-free days,  ICU-free days, and prevalence of acute kidney injury than FACTT Liberal. FACTT Lite can  be used as a simplified and safe alternative to FACTT Conservative for the management of  fluid balance in patients with ARDS. Supplementary Material Refer to Web version on PubMed Central for supplementary material. Acknowledgments Supported, in part, by the National Institutes of Health, National",8,76,0.8505194187164307
1,Does early administration of neuromuscular blocking agents increases the ventilator free days?,FMWSCPARDS.pdf," be easily understood and implemented by  physician and nursing staff in the ICU. Conclusions Although the FACTT Lite protocol had a greater cumulative fluid balance than FACTT  Conservative, the results of our study indicate that the FACTT Lite protocol is safe and has  equivalent ventilator-free days, ICU-free days, acute kidney injury, and adjusted 60-day  mortality to FACTT Conservative. FACTT Conservative has improved ventilator-free days,",8,75,0.8505194187164307
1,Does early administration of neuromuscular blocking agents increases the ventilator free days?,ETSDMV.pdf," [17,18,22,23]. The main side effects of  dexmedetomidine are bradycardia, hypotension and the potential for withdrawal symptoms  upon discontinuation of long-term therapy [17,18]. When compared to other sedatives,  dexmedetomidine has been shown to result in a more awake and interactive patient, a lower  incidence of delirium, more ventilator free days, and less days in the ICU [17–",3,26,0.8439829349517822
1,Does early administration of neuromuscular blocking agents increases the ventilator free days?,FMWSCPARDS.pdf,"; critical illness; fluid  therapy; shock Conservative fluid management improves ventilator-free days and oxygenation in patients  with the Acute Respiratory Distress Syndrome (ARDS). In the Fluid and Catheter Treatment  Trial (FACTT) of the National Institutes of Health, National Heart Lung and Blood Institute,  ARDS Network (NIH/NHLBI ARDS Network), patients were randomized and managed  with either a conservative fluid protocol (FACTT Conservative)",2,16,0.8276040554046631
1,Does early administration of neuromuscular blocking agents increases the ventilator free days?,SMDLTSWCI.pdf," 11, 14, 15]. Unlike other sedatives, dexmedetomidine—a highly  selective central alpha-2 adrenergic agonist with both  analgesic and sedative effects, notable for its ability to  provide light sedation, analgesia, and physiologic-like  sleep, as well as its minimal effect on respiratory drive— has been shown to result in a more awake and interactive  patient, a lower incidence of delirium, fewer days on ven- tilator",2,19,0.8245699405670166
1,Does early administration of neuromuscular blocking agents increases the ventilator free days?,ENB.pdf," severe ARDS for its  short-term benefit in early phase of disease. Prolonged use of NMBAs beyond 48 hours requires further study. (Cite this article as: Lyu T, Lee YS, Dhanvijay S, Freebairn R. The effect of neuromuscular blocking agents uses in acute  respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials. Minerva Anestesiol  2021;87:341-",1,9,0.823427677154541
1,Does early administration of neuromuscular blocking agents increases the ventilator free days?,ENB.pdf,"Vol. 87 - No. 3	 Minerva Anestesiologica	 341 R E V I E W The effect of neuromuscular blocking agents  uses in acute respiratory distress syndrome:  a systematic review and meta-analysis  of randomized controlled trials Ting LYU 1 *, Yee S. LEE 1, Shekhar DHANVIJAY 1, Ross FREEBAIRN 2 1Department of Intensive Care Medicine, Ng Teng Fong General Hospital,",1,1,0.823427677154541
1,Does early administration of neuromuscular blocking agents increases the ventilator free days?,DDS.pdf,"medetomidine in critically ill patients increased ventilator-free time [11] and decreased the incidence of postoperative complications, delirium, and mortality up to 1 year post-cardiac surgery [12]. In postoperative patients, dexmedetomidine provided sympatholytic ac- tivity [13]. It also offers anti-inflammatory and organ protective effects in animal models [14]. The use of dexmedetomidine as an anti-adrenergic strategy in se",1,6,0.8178668022155762
1,Does early administration of neuromuscular blocking agents increases the ventilator free days?,DDS.pdf," mediated by a blunted immune response, resulting in an improved microcirculation [7], or enhanced adrener- gic receptor sensitivity [8]. Dexmedetomidine is a highly selective alpha-2 adre- noreceptor agonist that has sedative, anxiolytic, and opioid-sparing effects (Table 2) [9, 10]. The use of dexmedetomidine in critically ill patients increased ventilator-free time [11] and decreased",1,5,0.8178668022155762
1,Does early administration of neuromuscular blocking agents increases the ventilator free days?,ESCNBC.pdf," The  COVID-19 Critical Care Consortium  Abstract  Background:  The role of neuromuscular blocking agents (NMBAs) in coronavirus disease 2019 (COVID-19) acute  respiratory distress syndrome (ARDS) is not fully elucidated. Therefore, we aimed to investigate in COVID-19 patients  with moderate-to-severe ARDS the impact of early use of NMBAs on 90-day mortality, through propensity score (PS)",1,6,0.8158602714538574
1,Does early administration of neuromuscular blocking agents increases the ventilator free days?,TOF-ARDS.pdf,"ourenne2 Abstract  Background:  Neuromuscular blocking agents (NMBAs) have been shown to improve the outcome of the most  severely hypoxemic, acute respiratory distress syndrome (ARDS) patients. However, the recommended dosage as  well as the necessity of monitoring the neuromuscular block is unknown. We aimed to evaluate the efficiency of a  nurse-directed protocol of NMBA administration based on a train-of-four (TOF) assessment",1,3,0.8104820251464844
1,Does early administration of neuromuscular blocking agents increases the ventilator free days?,ACURASYS.pdf," mechanical ventilation for the acute respiratory distress syn- drome (ARDS), neuromuscular blocking agents may improve oxygenation and de- crease ventilator-induced lung injury but may also cause muscle weakness. We evalu- ated clinical outcomes after 2 days of therapy with neuromuscular blocking agents in  patients with early, severe ARDS. Methods In this multicenter, double-blind trial, 340 patients presenting to the intensive care  unit (ICU) with an onset",1,11,0.8104820251464844
1,Does early administration of neuromuscular blocking agents increases the ventilator free days?,ACURASYS.pdf," des Bourrely, 13009 Marseille, France, or  at laurent.papazian@ap-hm.fr. *The ARDS et Curarisation Systematique  (ACURASYS) study investigators are  listed in the Appendix. N Engl J Med 2010;363:1107-16. Copyright © 2010 Massachusetts Medical Society. Background In patients undergoing mechanical ventilation for the acute respiratory distress syn- drome (ARDS), neuromuscular blocking agents",1,10,0.8104820251464844
1,Does early administration of neuromuscular blocking agents increases the ventilator free days?,TOF-ARDS.pdf,"/kg of predicted body weight  (PBW) [2], a short course of neuromuscular blocking  agents (NMBAs) [3] in severely hypoxemic patients, and  the use of prone positioning (PP) [4]. NMBAs are fre- quently used in the most severe forms of ARDS [1]. They  are the only pharmacologic intervention that has been  shown to improve the prognosis of moderate-to-severe  ARDS",1,12,0.8104820251464844
1,Does early administration of neuromuscular blocking agents increases the ventilator free days?,HDDSICU.pdf,". Results showed that patients treated with dexmedetomidine experienced a comparable level of sedation, spent less time on the ventilator, experi- enced less delirium, and developed less tachycardia and hypertension.  Both the MENDS and SEDCOM trials used higher dexmedetomidine doses for longer durations than those previously studied and showed similar efficacy and safety outcomes.5,11 However, neither study assessed the impact of doses greater than 0.7",2,15,0.8028988838195801
2,Do patients with severe ARDS being treated with neuromuscular blocking agents have increased muscle weakness?,LSPA.pdf,"–31 or  high PEEP strategies32,33 that are often employed for management of ARDS. However, deep  sedation is required in patients with ARDS who receive neuromuscular blockage to ensure  patients do not consciously experience paralysis.34,35 Neuromuscular blockage is sometimes  used in severe ARDS based on results of a multicenter trial in France that showed improved  mortality with 48 hours of neuromuscular blockage in patients who have severe",3,23,0.9385466575622559
2,Do patients with severe ARDS being treated with neuromuscular blocking agents have increased muscle weakness?,NBSARDS.pdf," how NMB agents are used in patients with ARDS. A very high proportion (96.6%) of intensivists who treat patients with moderate to severe ARDS use NMB, and almost 40% of these respondents use NMB in more than half their patients with moderate to severe ARDS. These results are in line with other recent surveys. The LUNG SAFE study, a prospective study of 459 ICUs in 50 countries conducted in the winter of 2014, found that 37",5,59,0.8736917972564697
2,Do patients with severe ARDS being treated with neuromuscular blocking agents have increased muscle weakness?,ROSE.pdf,"ade (ROSE) trial —  a multicenter, unblinded, randomized trial of  patients with moderate-to-severe ARDS — to  determine the efficacy and safety of early neuro- muscular blockade with concomitant heavy se- dation as compared with a strategy of usual  care with lighter sedation targets. We hypothe- sized that the use of early neuromuscular block- ade would result in lower all-cause in-hospital  mortality at 90 days",2,22,0.8696675300598145
2,Do patients with severe ARDS being treated with neuromuscular blocking agents have increased muscle weakness?,APV.pdf," ventilation variables have to be properly adjusted during ventilatory therapy, which generally requires continuous care from clinical staff, es- pecially for patients with severe ARDS. To minimize the workload of daily clinical practice and to maintain the standard protocol of protective ventilation, we introduce automatic control of ventilation as a concept for the treatment. In this article, we describe a strategy of auto- matic ventilation in ARDS patients, including continu- ous monitoring of regional ventilation at thoracic cavity using electrical impedance",2,18,0.8652796745300293
2,Do patients with severe ARDS being treated with neuromuscular blocking agents have increased muscle weakness?,ACURASYS.pdf," mechanical ventilation for the acute respiratory distress syn- drome (ARDS), neuromuscular blocking agents may improve oxygenation and de- crease ventilator-induced lung injury but may also cause muscle weakness. We evalu- ated clinical outcomes after 2 days of therapy with neuromuscular blocking agents in  patients with early, severe ARDS. Methods In this multicenter, double-blind trial, 340 patients presenting to the intensive care  unit (ICU) with an onset",1,11,0.8588335514068604
2,Do patients with severe ARDS being treated with neuromuscular blocking agents have increased muscle weakness?,EDPMARDSLPMV.pdf," this result may be due to the wide range of VT used across the trials included. To try to answer this question, we investigated ΔPrs from two trials [4, 5] in which strict lung- protective mechanical ventilation, in particular 6 ml/kg predicted body weight VT, was applied to patients with ARDS. Our working hypothesis was that ΔPrs was asso- ciated with death, just like compliance (Crs) or Pplat,rs. Methods This is a",2,18,0.8582408428192139
2,Do patients with severe ARDS being treated with neuromuscular blocking agents have increased muscle weakness?,CEIIUPPSARDS.pdf, Setting: Intensive care units that care for patients with ARDS. Subjects: Patients with moderate to severe ARDS. For reprints : Corresponding Author: Cameron M Baston. 3400 Spruce St. Philadelphia PA 19104. cbass@alum.mit.edu  +12159133239.  The work was performed at the University of Pennsylvania Declaration of Conflict of Interest: The authors have disclosed that they do not have any conflicts of interest. HHS Public Access Author manuscript Crit,1,6,0.8582408428192139
2,Do patients with severe ARDS being treated with neuromuscular blocking agents have increased muscle weakness?,CEIIUPPSARDS.pdf,"ri F, Pugliese F, Ranieri VM. The Role of Rescue Therapies in the Treatment of Severe  ARDS. Respiratory care 2018;63(1):92–101. [PubMed: 29066591]  9. Li X, Scales DC, Kavanagh BP. Unproven and Expensive Before Proven and Cheap - Extracorporeal  Membrane Oxygenation vs. Prone Position in ARDS. American journal of",8,73,0.8507289886474609
2,Do patients with severe ARDS being treated with neuromuscular blocking agents have increased muscle weakness?,ESCNBC.pdf,"Li Bassi et al. Critical Care          (2022) 26:141   https://doi.org/10.1186/s13054-022-03983-5 RESEARCH Early short course of neuromuscular  blocking agents in patients with COVID‑19  ARDS: a propensity score analysis Gianluigi Li Bassi1,2,",1,1,0.8477845191955566
2,Do patients with severe ARDS being treated with neuromuscular blocking agents have increased muscle weakness?,APV.pdf," the formation of noncardiogenic pulmonary edema and inacti- vation of surfactant, leading to alveolar collapse and atelec- tasis. Progressive hypoxia and an increased work of breathing are then unavoidable. At the onset, ventilation support with mechanical ventilation is generally required. Since 2000, protective ventilation using the Acute Re- spiratory Distress Syndrome Network (ARDSNet) proto- col has continued to be the cornerstone in intensive care for ARDS therapy",2,14,0.8446857929229736
2,Do patients with severe ARDS being treated with neuromuscular blocking agents have increased muscle weakness?,CEIIUPPSARDS.pdf,"entered automatically for patients identified by the electronic health record as being eligible  for PP, then hospitals who admitted few eligible patients should be willing to support it (29). Alternatively, an integrated health system that also insures its beneficiaries might consider  all costs, including additional downstream costs of survivors, making the results of our  societal model more relevant. Suppose such a system was willing to pay $50,000 per QALY  gained and admitted 200 patients with moderate-severe ARDS annually.",6,47,0.8440487384796143
2,Do patients with severe ARDS being treated with neuromuscular blocking agents have increased muscle weakness?,OSCILLATE.pdf,"DS.23-26 We therefore compared HFOV  with a conventional ventilation strategy that used  low tidal volumes and high levels of PEEP in pa- tients with new-onset, moderate-to-severe ARDS. Methods Study Oversight For the pilot phase of the study, we enrolled pa- tients at 11 centers in Canada and 1 in Saudi  Arabia from July 2007 through June 2008; for the  main trial, we enrolled patients at the same cen- ters",2,25,0.8414995670318604
2,Do patients with severe ARDS being treated with neuromuscular blocking agents have increased muscle weakness?,PPATDSHMA.pdf,"occa, Milan, Italy c Department of Anesthesia and Intensive Care, Niguarda Hospital, Milan, Italy Received 7 August 2022; accepted 25 December 2022 Available online xxx Abstract Background: Researchers have tried unsuccessfully for many years using randomized controlled trials to show the efﬁcacy of prone ventilation in treating ARDS. These failed attempts were of use in designing the successful PROSEVA trial, published in 2013. However, the evidence provided by meta-analyses in",2,4,0.8398065567016602
2,Do patients with severe ARDS being treated with neuromuscular blocking agents have increased muscle weakness?,PTARDS.pdf," 17). An important role for platelets in ARDS has also been described (12). This pivotal role for platelet activation in ARDS pathogenesis represents an oppor- tunity for a treatment strategy with ASA, and several studies, human and animal, have been undertaken testing the role of platelet inhibition in ARDS. We chose to study one specific antiplatelet agent in ARDS to produce a more homogeneous analysis. ASA is the most used and studied antiplatelet therapy, has",1,14,0.8398065567016602
2,Do patients with severe ARDS being treated with neuromuscular blocking agents have increased muscle weakness?,NBSARDS.pdf," original ACURASYS trial13 re- sults in the decision to initiate NMB treatment in ARDS patients. We included 4 identically-worded questions ask- ing the respondents to grade the importance they placed on each of 4 potential justifications for starting NMB in pa- tients with moderate to severe ARDS. Based on a mean weighted score, the most important indication for initiating NMB in patients with moderate to severe ARDS was to allow compliance with ARDSNet mechanical ventilation",5,65,0.8339507579803467
2,Do patients with severe ARDS being treated with neuromuscular blocking agents have increased muscle weakness?,ESCNBC.pdf,". Interna- tional studies have confirmed the use of NMBAs in up to  26% of ARDS patients [14]. Yet, conflicting results were  provided by large randomized clinical trials, such as the  ACURASYS [15] and ROSE trials [16], and indication,  efficacy, and safety on the use of NMBAs in such patients  remain uncertain. The severe respiratory failure associated with COVID- 19 has been described as a form of ARDS",2,20,0.8339507579803467
2,Do patients with severe ARDS being treated with neuromuscular blocking agents have increased muscle weakness?,NBSARDS.pdf,"13 and ROSE trials,26 moderate to severe ARDS in the survey was de- fined as PaO2/FIO2  150 mm Hg, along with other Berlin criteria. The survey was approved by the University of Maryland School of Medicine Institutional Review Board. The survey writing team generated an initial 16-ques- tion survey that included 6 demographic questions, 3 ques- tions about whether the respondent managed patients with ARDS and whether they used NMB in their management",2,22,0.8296747207641602
3,"In patients with moderate to severe ARDS, does early use of continuous neuromuscular blockade improve mortality?",LSPA.pdf,"–31 or  high PEEP strategies32,33 that are often employed for management of ARDS. However, deep  sedation is required in patients with ARDS who receive neuromuscular blockage to ensure  patients do not consciously experience paralysis.34,35 Neuromuscular blockage is sometimes  used in severe ARDS based on results of a multicenter trial in France that showed improved  mortality with 48 hours of neuromuscular blockage in patients who have severe",3,23,0.9309053421020508
3,"In patients with moderate to severe ARDS, does early use of continuous neuromuscular blockade improve mortality?",RARDS.pdf," ARDSnet trials showed no difference between patients with moderate–severe and mild–moderate ARDS in terms of mortality, even though there were differences in rapid resolution of ARDS, ventilator-free days, and ICU-free days. Author disclosures are available with the text of this article at www.atsjournals.org. Acknowledgment: The authors are grateful to the investigators of ARDS Network (ARDSNet) trials for collecting the data on which this analysis was based,",3,42,0.8712306022644043
3,"In patients with moderate to severe ARDS, does early use of continuous neuromuscular blockade improve mortality?",ROSE.pdf,"ade (ROSE) trial —  a multicenter, unblinded, randomized trial of  patients with moderate-to-severe ARDS — to  determine the efficacy and safety of early neuro- muscular blockade with concomitant heavy se- dation as compared with a strategy of usual  care with lighter sedation targets. We hypothe- sized that the use of early neuromuscular block- ade would result in lower all-cause in-hospital  mortality at 90 days",2,22,0.8641161918640137
3,"In patients with moderate to severe ARDS, does early use of continuous neuromuscular blockade improve mortality?",NBSARDS.pdf," how NMB agents are used in patients with ARDS. A very high proportion (96.6%) of intensivists who treat patients with moderate to severe ARDS use NMB, and almost 40% of these respondents use NMB in more than half their patients with moderate to severe ARDS. These results are in line with other recent surveys. The LUNG SAFE study, a prospective study of 459 ICUs in 50 countries conducted in the winter of 2014, found that 37",5,59,0.8626987934112549
3,"In patients with moderate to severe ARDS, does early use of continuous neuromuscular blockade improve mortality?",CEIIUPPSARDS.pdf,"entered automatically for patients identified by the electronic health record as being eligible  for PP, then hospitals who admitted few eligible patients should be willing to support it (29). Alternatively, an integrated health system that also insures its beneficiaries might consider  all costs, including additional downstream costs of survivors, making the results of our  societal model more relevant. Suppose such a system was willing to pay $50,000 per QALY  gained and admitted 200 patients with moderate-severe ARDS annually.",6,47,0.8527176380157471
3,"In patients with moderate to severe ARDS, does early use of continuous neuromuscular blockade improve mortality?",BMIMSARDS.pdf,"Body Mass Index and Mortality in Subjects With ARDS: Post-hoc Analysis of the OSCILLATE Trial Haytham Tlayjeh, Yaseen M Arabi, Niall D Ferguson, Qi Zhou, Francois Lamontagne, Alejandro Arroliga, Valerie Danesh, Guillermo Dominguez-Cherit, Edgar Jimenez, Adam Mullaly, Brandon Staub, and Maureen O Meade; for the Canadian Critical Care Trials Group BACK",1,1,0.8506574630737305
3,"In patients with moderate to severe ARDS, does early use of continuous neuromuscular blockade improve mortality?",TOF-ARDS.pdf,"/kg of predicted body weight  (PBW) [2], a short course of neuromuscular blocking  agents (NMBAs) [3] in severely hypoxemic patients, and  the use of prone positioning (PP) [4]. NMBAs are fre- quently used in the most severe forms of ARDS [1]. They  are the only pharmacologic intervention that has been  shown to improve the prognosis of moderate-to-severe  ARDS",1,12,0.8451581001281738
3,"In patients with moderate to severe ARDS, does early use of continuous neuromuscular blockade improve mortality?",ACURASYS.pdf," mechanical ventilation for the acute respiratory distress syn- drome (ARDS), neuromuscular blocking agents may improve oxygenation and de- crease ventilator-induced lung injury but may also cause muscle weakness. We evalu- ated clinical outcomes after 2 days of therapy with neuromuscular blocking agents in  patients with early, severe ARDS. Methods In this multicenter, double-blind trial, 340 patients presenting to the intensive care  unit (ICU) with an onset",1,11,0.8446910381317139
3,"In patients with moderate to severe ARDS, does early use of continuous neuromuscular blockade improve mortality?",ESCNBC.pdf," The  COVID-19 Critical Care Consortium  Abstract  Background:  The role of neuromuscular blocking agents (NMBAs) in coronavirus disease 2019 (COVID-19) acute  respiratory distress syndrome (ARDS) is not fully elucidated. Therefore, we aimed to investigate in COVID-19 patients  with moderate-to-severe ARDS the impact of early use of NMBAs on 90-day mortality, through propensity score (PS)",1,6,0.8433651924133301
3,"In patients with moderate to severe ARDS, does early use of continuous neuromuscular blockade improve mortality?",CEIIUPPSARDS.pdf,"ri F, Pugliese F, Ranieri VM. The Role of Rescue Therapies in the Treatment of Severe  ARDS. Respiratory care 2018;63(1):92–101. [PubMed: 29066591]  9. Li X, Scales DC, Kavanagh BP. Unproven and Expensive Before Proven and Cheap - Extracorporeal  Membrane Oxygenation vs. Prone Position in ARDS. American journal of",8,73,0.840766429901123
3,"In patients with moderate to severe ARDS, does early use of continuous neuromuscular blockade improve mortality?",APV.pdf," ventilation variables have to be properly adjusted during ventilatory therapy, which generally requires continuous care from clinical staff, es- pecially for patients with severe ARDS. To minimize the workload of daily clinical practice and to maintain the standard protocol of protective ventilation, we introduce automatic control of ventilation as a concept for the treatment. In this article, we describe a strategy of auto- matic ventilation in ARDS patients, including continu- ous monitoring of regional ventilation at thoracic cavity using electrical impedance",2,18,0.838019847869873
3,"In patients with moderate to severe ARDS, does early use of continuous neuromuscular blockade improve mortality?",ESCNBC.pdf,"Li Bassi et al. Critical Care          (2022) 26:141   https://doi.org/10.1186/s13054-022-03983-5 RESEARCH Early short course of neuromuscular  blocking agents in patients with COVID‑19  ARDS: a propensity score analysis Gianluigi Li Bassi1,2,",1,1,0.8326091766357422
3,"In patients with moderate to severe ARDS, does early use of continuous neuromuscular blockade improve mortality?",OSCILLATE.pdf,"DS.23-26 We therefore compared HFOV  with a conventional ventilation strategy that used  low tidal volumes and high levels of PEEP in pa- tients with new-onset, moderate-to-severe ARDS. Methods Study Oversight For the pilot phase of the study, we enrolled pa- tients at 11 centers in Canada and 1 in Saudi  Arabia from July 2007 through June 2008; for the  main trial, we enrolled patients at the same cen- ters",2,25,0.8312351703643799
3,"In patients with moderate to severe ARDS, does early use of continuous neuromuscular blockade improve mortality?",ESCPARDS.pdf,"prednisolone did not increase  the rate of infectious complications but was associated with a higher rate of neuro- muscular weakness. Conclusions These results do not support the routine use of methylprednisolone for persistent  ARDS despite the improvement in cardiopulmonary physiology. In addition, start- ing methylprednisolone therapy more than two weeks after the onset of ARDS may  increase the risk of death. (ClinicalTrials.gov number, NCT00295269",1,10,0.8305258750915527
3,"In patients with moderate to severe ARDS, does early use of continuous neuromuscular blockade improve mortality?",CEIIUPPSARDS.pdf, Setting: Intensive care units that care for patients with ARDS. Subjects: Patients with moderate to severe ARDS. For reprints : Corresponding Author: Cameron M Baston. 3400 Spruce St. Philadelphia PA 19104. cbass@alum.mit.edu  +12159133239.  The work was performed at the University of Pennsylvania Declaration of Conflict of Interest: The authors have disclosed that they do not have any conflicts of interest. HHS Public Access Author manuscript Crit,1,6,0.8288090229034424
3,"In patients with moderate to severe ARDS, does early use of continuous neuromuscular blockade improve mortality?",EDPMARDSLPMV.pdf," this result may be due to the wide range of VT used across the trials included. To try to answer this question, we investigated ΔPrs from two trials [4, 5] in which strict lung- protective mechanical ventilation, in particular 6 ml/kg predicted body weight VT, was applied to patients with ARDS. Our working hypothesis was that ΔPrs was asso- ciated with death, just like compliance (Crs) or Pplat,rs. Methods This is a",2,18,0.8288090229034424
3,"In patients with moderate to severe ARDS, does early use of continuous neuromuscular blockade improve mortality?",PPATDSHMA.pdf," every time the PROSEVA study is excluded from a meta-analysis the p values for both effect and heterogeneity increase strikingly, whereas when other trials are omitted, they remain low with small variations. As shown in Table 2, the interaction test, which formally investigates the heterogeneity of effects across subgroups, was always signiﬁcant when the PROSEVA trial was compared with the rest of the studies. Discussion Prone ventilation is considered to be standard care for severe ARDS, and",4,40,0.8282098770141602
3,"In patients with moderate to severe ARDS, does early use of continuous neuromuscular blockade improve mortality?",NBSARDS.pdf,"13 and ROSE trials,26 moderate to severe ARDS in the survey was de- fined as PaO2/FIO2  150 mm Hg, along with other Berlin criteria. The survey was approved by the University of Maryland School of Medicine Institutional Review Board. The survey writing team generated an initial 16-ques- tion survey that included 6 demographic questions, 3 ques- tions about whether the respondent managed patients with ARDS and whether they used NMB in their management",2,22,0.8269100189208984
4,Do patients with moderate-to-severe ARDS have a significance difference in mortality rate between patients who recieved an early and continuous cisatracurium infusion than those with usual care approach with lighter sedation targets?,TOF-ARDS.pdf,"Hraiech et al. Ann. Intensive Care  (2017) 7:79  DOI 10.1186/s13613-017-0305-2 RESEARCH How to reduce cisatracurium  consumption in ARDS patients: the TOF‑ARDS  study Sami Hraiech1,3*, Jean‑Marie Forel1, Christophe Guervilly1, Romain Rambaud1, Samuel ",1,1,0.8267707824707031
4,Do patients with moderate-to-severe ARDS have a significance difference in mortality rate between patients who recieved an early and continuous cisatracurium infusion than those with usual care approach with lighter sedation targets?,ROSE.pdf,"ade (ROSE) trial —  a multicenter, unblinded, randomized trial of  patients with moderate-to-severe ARDS — to  determine the efficacy and safety of early neuro- muscular blockade with concomitant heavy se- dation as compared with a strategy of usual  care with lighter sedation targets. We hypothe- sized that the use of early neuromuscular block- ade would result in lower all-cause in-hospital  mortality at 90 days",2,22,0.8246076107025146
4,Do patients with moderate-to-severe ARDS have a significance difference in mortality rate between patients who recieved an early and continuous cisatracurium infusion than those with usual care approach with lighter sedation targets?,NBSARDS.pdf," how NMB agents are used in patients with ARDS. A very high proportion (96.6%) of intensivists who treat patients with moderate to severe ARDS use NMB, and almost 40% of these respondents use NMB in more than half their patients with moderate to severe ARDS. These results are in line with other recent surveys. The LUNG SAFE study, a prospective study of 459 ICUs in 50 countries conducted in the winter of 2014, found that 37",5,59,0.8223733901977539
4,Do patients with moderate-to-severe ARDS have a significance difference in mortality rate between patients who recieved an early and continuous cisatracurium infusion than those with usual care approach with lighter sedation targets?,BMIMSARDS.pdf,"Body Mass Index and Mortality in Subjects With ARDS: Post-hoc Analysis of the OSCILLATE Trial Haytham Tlayjeh, Yaseen M Arabi, Niall D Ferguson, Qi Zhou, Francois Lamontagne, Alejandro Arroliga, Valerie Danesh, Guillermo Dominguez-Cherit, Edgar Jimenez, Adam Mullaly, Brandon Staub, and Maureen O Meade; for the Canadian Critical Care Trials Group BACK",1,1,0.8146486282348633
4,Do patients with moderate-to-severe ARDS have a significance difference in mortality rate between patients who recieved an early and continuous cisatracurium infusion than those with usual care approach with lighter sedation targets?,CEIIUPPSARDS.pdf,"entered automatically for patients identified by the electronic health record as being eligible  for PP, then hospitals who admitted few eligible patients should be willing to support it (29). Alternatively, an integrated health system that also insures its beneficiaries might consider  all costs, including additional downstream costs of survivors, making the results of our  societal model more relevant. Suppose such a system was willing to pay $50,000 per QALY  gained and admitted 200 patients with moderate-severe ARDS annually.",6,47,0.8037803173065186
4,Do patients with moderate-to-severe ARDS have a significance difference in mortality rate between patients who recieved an early and continuous cisatracurium infusion than those with usual care approach with lighter sedation targets?,ACURASYS.pdf," mechanical ventilation for the acute respiratory distress syn- drome (ARDS), neuromuscular blocking agents may improve oxygenation and de- crease ventilator-induced lung injury but may also cause muscle weakness. We evalu- ated clinical outcomes after 2 days of therapy with neuromuscular blocking agents in  patients with early, severe ARDS. Methods In this multicenter, double-blind trial, 340 patients presenting to the intensive care  unit (ICU) with an onset",1,11,0.8025448322296143
4,Do patients with moderate-to-severe ARDS have a significance difference in mortality rate between patients who recieved an early and continuous cisatracurium infusion than those with usual care approach with lighter sedation targets?,PPATDSHMA.pdf," every time the PROSEVA study is excluded from a meta-analysis the p values for both effect and heterogeneity increase strikingly, whereas when other trials are omitted, they remain low with small variations. As shown in Table 2, the interaction test, which formally investigates the heterogeneity of effects across subgroups, was always signiﬁcant when the PROSEVA trial was compared with the rest of the studies. Discussion Prone ventilation is considered to be standard care for severe ARDS, and",4,40,0.8012244701385498
4,Do patients with moderate-to-severe ARDS have a significance difference in mortality rate between patients who recieved an early and continuous cisatracurium infusion than those with usual care approach with lighter sedation targets?,NBSARDS.pdf,"13 and ROSE trials,26 moderate to severe ARDS in the survey was de- fined as PaO2/FIO2  150 mm Hg, along with other Berlin criteria. The survey was approved by the University of Maryland School of Medicine Institutional Review Board. The survey writing team generated an initial 16-ques- tion survey that included 6 demographic questions, 3 ques- tions about whether the respondent managed patients with ARDS and whether they used NMB in their management",2,22,0.8011879920959473
5,"Among patients with ALI/ARDS, does a conservative fluid management strategy improves lung function and decrease ventilator days compared to liberal strategy?",FMWSCPARDS.pdf," mortality to FACTT Conservative. FACTT Conservative has improved ventilator-free days,  ICU-free days, and prevalence of acute kidney injury than FACTT Liberal. FACTT Lite can  be used as a simplified and safe alternative to FACTT Conservative for the management of  fluid balance in patients with ARDS. Supplementary Material Refer to Web version on PubMed Central for supplementary material. Acknowledgments Supported, in part, by the National Institutes of Health, National",8,76,0.8423879146575928
5,"Among patients with ALI/ARDS, does a conservative fluid management strategy improves lung function and decrease ventilator days compared to liberal strategy?",PAC-in-FACTT.pdf," AP, Bernard GR, Thompson  BT, Hayden D, deBoisblanc B, Connors AF, Jr., Hite  RD,  Harabin  AL:  Comparison  of  two  fluid- management strategies in acute lung injury. N Engl J  Med 2006, 354:2564-2575.    10.  Lemaire F: Suspension of the NIH ARDS Network  fluids and catheters treatment trial. Intensive Care  Med",3,37,0.8107426166534424
5,"Among patients with ALI/ARDS, does a conservative fluid management strategy improves lung function and decrease ventilator days compared to liberal strategy?",RARDS.pdf," Comparison of two ﬂuid-management strategies in acute lung injury. N Engl J Med 2006;354:2564– 2575. 11 Steinberg KP, Hudson LD, Goodman RB, Hough CL, Lanken PN, Hyzy R, et al.; National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Efﬁcacy and safety of corticosteroids for persistent acute respiratory distress syndrome",4,57,0.8107426166534424
5,"Among patients with ALI/ARDS, does a conservative fluid management strategy improves lung function and decrease ventilator days compared to liberal strategy?",RARDS.pdf,"end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med 2004;351:327–336. 10 Wiedemann HP, Wheeler AP, Bernard GR, Thompson BT, Hayden D, deBoisblanc B, et al.; National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Comparison of two ﬂuid-management strategies in acute lung injury. N Engl J Med",4,56,0.8107426166534424
5,"Among patients with ALI/ARDS, does a conservative fluid management strategy improves lung function and decrease ventilator days compared to liberal strategy?",DIHRFARDSNET.pdf,"–8. 10.1056/NEJM200005043421801. [6]. Comparison of Two Fluid-Management Strategies in Acute Lung Injury. New England Journal of  Medicine 2006;354:2564–75. 10.1056/NEJMoa062200. [7]. The National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS)  Clinical Trials Network, Rice TW, Wheeler AP, Thompson BT, Steingrub",4,36,0.8105475902557373
6,Does a conservative fluid management strategy result in a significant difference in mortality as the primary outcome?,FACTT.pdf," primary outcome of 60-day  mortality, the conservative strategy of fluid management improved lung function and  shortened the duration of mechanical ventilation and intensive care without in- creasing nonpulmonary-organ failures. These results support the use of a conserva- tive strategy of fluid management in patients with acute lung injury. (ClinicalTrials. gov number, NCT00281268.) The New England Journal of Medicine is produced by NEJM Group, a division of the Massachusetts Medical",1,11,0.8652496337890625
6,Does a conservative fluid management strategy result in a significant difference in mortality as the primary outcome?,FMWSCPARDS.pdf,"; critical illness; fluid  therapy; shock Conservative fluid management improves ventilator-free days and oxygenation in patients  with the Acute Respiratory Distress Syndrome (ARDS). In the Fluid and Catheter Treatment  Trial (FACTT) of the National Institutes of Health, National Heart Lung and Blood Institute,  ARDS Network (NIH/NHLBI ARDS Network), patients were randomized and managed  with either a conservative fluid protocol (FACTT Conservative)",2,16,0.8584544658660889
6,Does a conservative fluid management strategy result in a significant difference in mortality as the primary outcome?,RARDS.pdf," with Lower Tidal Volumes as Compared with Traditional Tidal Volumes for Acute Lung Injury and the Acute Respiratory Distress Syndrome (ARMA), Higher versus Lower Positive End-Expiratory Pressures in Patients with the Acute Respiratory Distress Syndrome (ALVEOLI), Comparison of Two Fluid-Management Strategies in Acute Lung Injury (FACTT), and Efﬁcacy and Safety of Corticosteroids for Persistent Acute",1,7,0.8471426963806152
6,Does a conservative fluid management strategy result in a significant difference in mortality as the primary outcome?,ARDSSRDRFMS.pdf, What This Study Adds to the Field: We report the novel ﬁnding that ARDS subphenotypes as identiﬁed by latent class analysis have a differential response to randomly assigned ﬂuid management strategy. ARDS subphenotype could be identiﬁed with excellent accuracy using three variables in three distinct patient cohorts. ORIGINAL ARTICLE 332 American Journal of Respiratory and Critical Care Medicine Volume 195 Number 3 | February 1 2017,2,34,0.8364853858947754
6,Does a conservative fluid management strategy result in a significant difference in mortality as the primary outcome?,ARDSSRDRFMS.pdf,"subphenotypesintwoseparaterandomizedcontrolled trials with differential response to positive end-expiratory pressure. Objectives: To identify these subphenotypes in a third ARDS cohort, to test whether subphenotypes respond differently to ﬂuid management strategy, and to develop a practical model for subphenotype identiﬁcation. Methods: We used latent class analysis of baseline clinical and plasma biomarker data to identify subphenotypes in FACTT (Flu",1,4,0.8364853858947754
6,Does a conservative fluid management strategy result in a significant difference in mortality as the primary outcome?,FMWSCPARDS.pdf,FACTT  Conservative) resulted in a lower cumulative fluid balance and better outcomes than a liberal fluid  protocol (FACTT Liberal). Subsequent Acute Respiratory Distress Syndrome Network studies  *See also p. 477 The members of the National Institutes of Health/National Heart Lung and Blood Institute Acute Respiratory Distress Syndrome  Network are listed in Appendix 1. Institutions where this work was performed: Data analysis and article preparation were performed at Intermountain Medical Center,1,6,0.8300995826721191
6,Does a conservative fluid management strategy result in a significant difference in mortality as the primary outcome?,FMWSCPARDS.pdf,"monary and Critical Care Medicine, Baystate Medical Center, Springfield, MA 9Respiratory Institute, Cleveland Clinic, Cleveland, OH 10Department of Anesthesiology, University of Maryland, Baltimore, MD Abstract Objectives—In the Fluid and Catheter Treatment Trial (FACTT) of the National Institutes of  Health Acute Respiratory Distress Syndrome Network, a conservative fluid protocol (FACTT  Conservative) resulted in a lower cumulative fluid balance and better outcomes than a liberal fluid",1,5,0.8300995826721191
7,Does mechanical ventilation with a lower tidal volume result in decreased mortality with acute lung injury and acute respiratory distress syndrome?,RARDS.pdf," Thompson BT, Wheeler A; Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000;342:1301–1308. 9 Brower RG, Lanken PN, MacIntyre N, Matthay MA, Morris A, Ancukiewicz M, et al.; National Heart, Lung, and Blood Institute ARDS Clinical Trials Network. Higher",3,52,0.9633128643035889
7,Does mechanical ventilation with a lower tidal volume result in decreased mortality with acute lung injury and acute respiratory distress syndrome?,ARDSNet.pdf,"Volume 342 Number 18 · 1301 The New England Journal of Medicine © Copyright, 2000, by the Massachusetts Medical Society VOLUME 342 MAY 4, 2000 NUMBER 18 VENTILATION WITH LOWER TIDAL VOLUMES AS COMPARED WITH  TRADITIONAL TIDAL VOLUMES FOR ACUTE LUNG INJURY AND THE ACUTE RESPIRATORY DISTRESS SYNDROME THE ACUTE RESPIRATORY DISTRESS SYNDROME NETWORK",1,1,0.9633128643035889
7,Does mechanical ventilation with a lower tidal volume result in decreased mortality with acute lung injury and acute respiratory distress syndrome?,EDPMARDSLPMV.pdf,"ôpitaux de Marseille Department of Research and Innovation Support Unit for clinical research and economic evaluation, Marseille 13005, France. Received: 17 August 2016 Accepted: 2 November 2016 References 1. ARDSnet. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med. 2000;342(18):1301–8. 2. Amato",8,97,0.9633128643035889
7,Does mechanical ventilation with a lower tidal volume result in decreased mortality with acute lung injury and acute respiratory distress syndrome?,ENB.pdf,≤30  cm H20 AECC: American-European Consensus Conference; ARDS: Acute Respiratory Distress Syndrome; PaO2/FiO2: partial pressure of oxygen/ fractional inspired oxygen; PEEP: positive end expiratory pressure; TOF: train of four; ARDSnet protocol: ventilation with lower tidal  volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome; NO: nitric oxide; ,4,60,0.9630706310272217
7,Does mechanical ventilation with a lower tidal volume result in decreased mortality with acute lung injury and acute respiratory distress syndrome?,HARDST.pdf,"ere JG, Mullen JB, Gan K, Slutsky AS. Tidal ventilation at low airway pressures can augment lung injury. Am J Respir Crit Care Med. 1994;149:1327–34. 22. Caironi P, Cressoni M, Chiumello D, Ranieri M, Quintel M, Russo SG, et al. Lung opening and closing during ventilation of acute respiratory distress syndrome. Am J Respir Crit Care Med. 2010;",3,42,0.9177660942077637
7,Does mechanical ventilation with a lower tidal volume result in decreased mortality with acute lung injury and acute respiratory distress syndrome?,NBSARDS.pdf," J Med 2004;351(4):327-336. 22. Meade MO, Cook DJ, Guyatt GH, Slutsky AS, Arabi YM, Cooper DJ, et al. Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome: a randomized con- trolled trial. JAMA 2008;299(6):637-645. 23. Mercat A, Richard JC",7,95,0.8895728588104248
7,Does mechanical ventilation with a lower tidal volume result in decreased mortality with acute lung injury and acute respiratory distress syndrome?,ENB.pdf,"OSE trial  specifically mentioned the reason to use fixed  dose was to replicate the dosing regimen used  in the (ACURASYS) trial and to facilitate ad­ herence to the trial protocol.11, 15 All the studies  used lung protective ventilation with low tidal  volume with an aim of keeping plateau pres­ sure ≤30 cm H2O. It is also noted ACURASYS  and ROSE trials used one bolus NMDA per 24  hours in control group",4,52,0.8883187770843506
7,Does mechanical ventilation with a lower tidal volume result in decreased mortality with acute lung injury and acute respiratory distress syndrome?,CEIIUPPSARDS.pdf," medicine 2017:1–16. 12. Cooke CR, Kahn JM, Watkins TR, et al. Cost-effectiveness of implementing low-tidal volume  ventilation in patients with acute lung injury. CHEST Journal 2009;136(1):79–88. 13. Weiss CH, Baker DW, Tulas K, et al. A critical care clinician survey comparing attitudes and  perceived barriers to low tidal volume ventilation with actual practice. Annals of the American  Thoracic Society",8,76,0.8743646144866943
7,Does mechanical ventilation with a lower tidal volume result in decreased mortality with acute lung injury and acute respiratory distress syndrome?,CEIIUPPSARDS.pdf,"02]  7. Weiss CH, McSparron JI, Chatterjee RS, et al. Summary for Clinicians: Mechanical Ventilation in  Adult Patients with Acute Respiratory Distress Syndrome Clinical Practice Guideline. Ann Am  Thorac Soc 2017;14(8):1235–1238. [PubMed: 28763269]  8. Alessandri F, Pugliese F, Ranieri VM. The Role of Rescue Therapies in",8,72,0.8488991260528564
7,Does mechanical ventilation with a lower tidal volume result in decreased mortality with acute lung injury and acute respiratory distress syndrome?,ARDSNet.pdf,VENTILATION WITH LOWER TIDAL VOLUMES IN PATIENTS WITH THE ACUTE RESPIRATORY DISTRESS SYNDROME Volume 342 Number 18 · 1305 incidence of barotrauma after randomization was sim- ilar in the two groups. There were no significant differences between groups in the percentages of days on which neuro- muscular-blocking drugs were used among patients who were discharged home and breathing without assistance (6±14 percent in the group treated with lower,5,69,0.8462350368499756
7,Does mechanical ventilation with a lower tidal volume result in decreased mortality with acute lung injury and acute respiratory distress syndrome?,RARDS.pdf," Aerosolized b2-Agonist for Treatment of Acute Lung Injury (ALTA), Initial Trophic vs Full Enteral Feeding in Patients With Acute Lung Injury (EDEN), and Rosuvastatin for Sepsis-Associated Acute Respiratory Distress Syndrome (SAILS) (5–7). For this analysis, we excluded individuals from the Ventilation with Lower Tidal Volumes as Compared with Traditional Tidal Volumes for Acute Lung Injury and",1,6,0.8458149433135986
7,Does mechanical ventilation with a lower tidal volume result in decreased mortality with acute lung injury and acute respiratory distress syndrome?,ARDSSRDRFMS.pdf,", we used data from two randomized controlled trials (RCTs), ARMA and ALVEOLI (Assessment of Low tidal Volume and elevated End- expiratory volume to Obviate Lung Injury) (2, 4). Remarkably, these separate data- driven analyses identiﬁed two very similar subphenotypes in each trial. Subphenotype 2 was associated with increased levels of inﬂammatory biomarkers, acidosis, and shock and was",2,18,0.8426718711853027
7,Does mechanical ventilation with a lower tidal volume result in decreased mortality with acute lung injury and acute respiratory distress syndrome?,LSPA.pdf," of Chest Physicians and the American  Thoracic Society recommend using a sedation protocol to minimize sedation of  mechanically ventilated ICU patients.28 Balanced against the recommendation for light sedation is the occasional need for deep  sedation during advanced therapies for severe ARDS. A number of studies have shown that  deep sedation is not required for patients to tolerate the low tidal volume ventilation29–31 or  high PEEP strategies32,33 that are often employed for management of ARDS",3,22,0.83512282371521
7,Does mechanical ventilation with a lower tidal volume result in decreased mortality with acute lung injury and acute respiratory distress syndrome?,LSPA.pdf,"individual patient data meta-analysis. Intensive care medicine. Jul; 2014 40(7):950–957. [PubMed:  24811940]  30. Kahn JM, Andersson L, Karir V, Polissar NL, Neff MJ, Rubenfeld GD. Low tidal volume  ventilation does not increase sedation use in patients with acute lung injury. Critical care medicine.  Apr; 2005 33(4):766–771. [PubMed",9,85,0.83512282371521
7,Does mechanical ventilation with a lower tidal volume result in decreased mortality with acute lung injury and acute respiratory distress syndrome?,HARDST.pdf," Tidal volume, driving pressure, flow, and respiratory rate have been identified as causes of ventilation-induced lung injury. Taken together, they represent the mechanical power applied to the lung parenchyma. In an inhomogeneous lung, stress risers locally increase the applied mechanical power. Increasing lung homogeneity by PEEP and prone position decreases the harm of mechanical ventilation, particularly in severe ARDS. Various etiologies can induce an inflammatory process in the lung parenchyma. In some",1,2,0.8348536491394043
7,Does mechanical ventilation with a lower tidal volume result in decreased mortality with acute lung injury and acute respiratory distress syndrome?,HARDST.pdf,". Intensive Care Med. 1990;16:372–7. 20. Chiumello D, Carlesso E, Cadringher P, Caironi P, Valenza F, Polli F, et al. Lung stress and strain during mechanical ventilation for acute respiratory distress syndrome. Am J Respir Crit Care Med. 2008;178:346–55. 21. Muscedere JG, Mullen JB, Gan K, Slutsky AS. Tidal ventilation",3,41,0.8340630531311035
7,Does mechanical ventilation with a lower tidal volume result in decreased mortality with acute lung injury and acute respiratory distress syndrome?,CEIIUPPSARDS.pdf,"]  5. Fan E, Del Sorbo L, Goligher EC, et al. An Official American Thoracic Society/European Society of  Intensive Care Medicine/Society of Critical Care Medicine Clinical Practice Guideline: Mechanical  Ventilation in Adult Patients with Acute Respiratory Distress Syndrome. American journal of  respiratory and critical care medicine 2017;195(9):1253–1263. [PubMed: 28459336]  6. Bein T",8,70,0.8311862945556641
7,Does mechanical ventilation with a lower tidal volume result in decreased mortality with acute lung injury and acute respiratory distress syndrome?,CEIIUPPSARDS.pdf," assumptions. Keywords Respiratory Distress Syndrome; Adult; Cost-Benefit Analysis; Prone position; Economics;  Hospital; Decision Trees Introduction: Despite recent advances, survival following the acute respiratory distress syndrome (ARDS)  remains 50-60% in many settings (1–4). Prone positioning (PP) in moderate-severe ARDS  has been shown in randomized trials to substantially improve survival, and, like low-tidal- volume ventilation (LTV), is a",2,12,0.8289682865142822
7,Does mechanical ventilation with a lower tidal volume result in decreased mortality with acute lung injury and acute respiratory distress syndrome?,HARDST.pdf,", Blanch L, Murias G, Adams AB, Olson DA, Wangensteen OD, et al. Effects of decreased respiratory frequency on ventilator-induced lung injury. Am J Respir Crit Care Med. 2000;161(2 Pt 1):463–8. 28. Fujita Y, Fujino Y, Uchiyama A, Mashimo T, Nishimura M. High peak inspiratory flow can aggravate ventilator-induced lung injury in rabbits. Med",3,46,0.824648380279541
8,Does mechanical ventilation with a lower tidal volume result increased ventilator free days with patients with acute lung injury and acute respiratory distress syndrome?,ARDSNet.pdf,"Volume 342 Number 18 · 1301 The New England Journal of Medicine © Copyright, 2000, by the Massachusetts Medical Society VOLUME 342 MAY 4, 2000 NUMBER 18 VENTILATION WITH LOWER TIDAL VOLUMES AS COMPARED WITH  TRADITIONAL TIDAL VOLUMES FOR ACUTE LUNG INJURY AND THE ACUTE RESPIRATORY DISTRESS SYNDROME THE ACUTE RESPIRATORY DISTRESS SYNDROME NETWORK",1,1,0.9403524398803711
8,Does mechanical ventilation with a lower tidal volume result increased ventilator free days with patients with acute lung injury and acute respiratory distress syndrome?,RARDS.pdf," Thompson BT, Wheeler A; Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000;342:1301–1308. 9 Brower RG, Lanken PN, MacIntyre N, Matthay MA, Morris A, Ancukiewicz M, et al.; National Heart, Lung, and Blood Institute ARDS Clinical Trials Network. Higher",3,52,0.9403524398803711
8,Does mechanical ventilation with a lower tidal volume result increased ventilator free days with patients with acute lung injury and acute respiratory distress syndrome?,EDPMARDSLPMV.pdf,"ôpitaux de Marseille Department of Research and Innovation Support Unit for clinical research and economic evaluation, Marseille 13005, France. Received: 17 August 2016 Accepted: 2 November 2016 References 1. ARDSnet. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med. 2000;342(18):1301–8. 2. Amato",8,97,0.9403524398803711
8,Does mechanical ventilation with a lower tidal volume result increased ventilator free days with patients with acute lung injury and acute respiratory distress syndrome?,ENB.pdf,≤30  cm H20 AECC: American-European Consensus Conference; ARDS: Acute Respiratory Distress Syndrome; PaO2/FiO2: partial pressure of oxygen/ fractional inspired oxygen; PEEP: positive end expiratory pressure; TOF: train of four; ARDSnet protocol: ventilation with lower tidal  volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome; NO: nitric oxide; ,4,60,0.9402601718902588
8,Does mechanical ventilation with a lower tidal volume result increased ventilator free days with patients with acute lung injury and acute respiratory distress syndrome?,HARDST.pdf,"ere JG, Mullen JB, Gan K, Slutsky AS. Tidal ventilation at low airway pressures can augment lung injury. Am J Respir Crit Care Med. 1994;149:1327–34. 22. Caironi P, Cressoni M, Chiumello D, Ranieri M, Quintel M, Russo SG, et al. Lung opening and closing during ventilation of acute respiratory distress syndrome. Am J Respir Crit Care Med. 2010;",3,42,0.8957417011260986
8,Does mechanical ventilation with a lower tidal volume result increased ventilator free days with patients with acute lung injury and acute respiratory distress syndrome?,NBSARDS.pdf," J Med 2004;351(4):327-336. 22. Meade MO, Cook DJ, Guyatt GH, Slutsky AS, Arabi YM, Cooper DJ, et al. Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome: a randomized con- trolled trial. JAMA 2008;299(6):637-645. 23. Mercat A, Richard JC",7,95,0.87813401222229
8,Does mechanical ventilation with a lower tidal volume result increased ventilator free days with patients with acute lung injury and acute respiratory distress syndrome?,CEIIUPPSARDS.pdf," medicine 2017:1–16. 12. Cooke CR, Kahn JM, Watkins TR, et al. Cost-effectiveness of implementing low-tidal volume  ventilation in patients with acute lung injury. CHEST Journal 2009;136(1):79–88. 13. Weiss CH, Baker DW, Tulas K, et al. A critical care clinician survey comparing attitudes and  perceived barriers to low tidal volume ventilation with actual practice. Annals of the American  Thoracic Society",8,76,0.8661749362945557
8,Does mechanical ventilation with a lower tidal volume result increased ventilator free days with patients with acute lung injury and acute respiratory distress syndrome?,ENB.pdf,"OSE trial  specifically mentioned the reason to use fixed  dose was to replicate the dosing regimen used  in the (ACURASYS) trial and to facilitate ad­ herence to the trial protocol.11, 15 All the studies  used lung protective ventilation with low tidal  volume with an aim of keeping plateau pres­ sure ≤30 cm H2O. It is also noted ACURASYS  and ROSE trials used one bolus NMDA per 24  hours in control group",4,52,0.8550364971160889
8,Does mechanical ventilation with a lower tidal volume result increased ventilator free days with patients with acute lung injury and acute respiratory distress syndrome?,CEIIUPPSARDS.pdf,"02]  7. Weiss CH, McSparron JI, Chatterjee RS, et al. Summary for Clinicians: Mechanical Ventilation in  Adult Patients with Acute Respiratory Distress Syndrome Clinical Practice Guideline. Ann Am  Thorac Soc 2017;14(8):1235–1238. [PubMed: 28763269]  8. Alessandri F, Pugliese F, Ranieri VM. The Role of Rescue Therapies in",8,72,0.8476173877716064
8,Does mechanical ventilation with a lower tidal volume result increased ventilator free days with patients with acute lung injury and acute respiratory distress syndrome?,HARDST.pdf,", Blanch L, Murias G, Adams AB, Olson DA, Wangensteen OD, et al. Effects of decreased respiratory frequency on ventilator-induced lung injury. Am J Respir Crit Care Med. 2000;161(2 Pt 1):463–8. 28. Fujita Y, Fujino Y, Uchiyama A, Mashimo T, Nishimura M. High peak inspiratory flow can aggravate ventilator-induced lung injury in rabbits. Med",3,46,0.837775468826294
8,Does mechanical ventilation with a lower tidal volume result increased ventilator free days with patients with acute lung injury and acute respiratory distress syndrome?,ETSDMV.pdf,"▪ Randomized placebo-controlled clinical trial of low dose nighttime  dexmedetomidine to prevent ICU delirium. Notable for being one of the few interventions shown  to prevent ICU delirium. 30. Kawazoe Y, Miyamoto K, Morimoto T, et al. Effect of dexmedetomidine on mortality and  ventilator-free days in patients requiring mechanical ventilation with sepsis: a randomized clinical  trial effect of dexmed",8,82,0.8358793258666992
8,Does mechanical ventilation with a lower tidal volume result increased ventilator free days with patients with acute lung injury and acute respiratory distress syndrome?,CEIIUPPSARDS.pdf,"]  5. Fan E, Del Sorbo L, Goligher EC, et al. An Official American Thoracic Society/European Society of  Intensive Care Medicine/Society of Critical Care Medicine Clinical Practice Guideline: Mechanical  Ventilation in Adult Patients with Acute Respiratory Distress Syndrome. American journal of  respiratory and critical care medicine 2017;195(9):1253–1263. [PubMed: 28459336]  6. Bein T",8,70,0.8279781341552734
8,Does mechanical ventilation with a lower tidal volume result increased ventilator free days with patients with acute lung injury and acute respiratory distress syndrome?,LSPA.pdf," Mehta S, Cook DJ, Skrobik Y, et al. A ventilator strategy combining low tidal volume ventilation,  recruitment maneuvers, and high positive end-expiratory pressure does not increase sedative,  opioid, or neuromuscular blocker use in adults with acute respiratory distress syndrome and may  improve patient comfort. Annals of intensive care. 2014; 4:33. [PubMed: 25593749]  34. Bein T, Grasso",9,88,0.8270058631896973
8,Does mechanical ventilation with a lower tidal volume result increased ventilator free days with patients with acute lung injury and acute respiratory distress syndrome?,ARDSSRDRFMS.pdf,", we used data from two randomized controlled trials (RCTs), ARMA and ALVEOLI (Assessment of Low tidal Volume and elevated End- expiratory volume to Obviate Lung Injury) (2, 4). Remarkably, these separate data- driven analyses identiﬁed two very similar subphenotypes in each trial. Subphenotype 2 was associated with increased levels of inﬂammatory biomarkers, acidosis, and shock and was",2,18,0.8233542442321777
8,Does mechanical ventilation with a lower tidal volume result increased ventilator free days with patients with acute lung injury and acute respiratory distress syndrome?,HARDST.pdf," Tidal volume, driving pressure, flow, and respiratory rate have been identified as causes of ventilation-induced lung injury. Taken together, they represent the mechanical power applied to the lung parenchyma. In an inhomogeneous lung, stress risers locally increase the applied mechanical power. Increasing lung homogeneity by PEEP and prone position decreases the harm of mechanical ventilation, particularly in severe ARDS. Various etiologies can induce an inflammatory process in the lung parenchyma. In some",1,2,0.8206479549407959
8,Does mechanical ventilation with a lower tidal volume result increased ventilator free days with patients with acute lung injury and acute respiratory distress syndrome?,HARDST.pdf,". Intensive Care Med. 1990;16:372–7. 20. Chiumello D, Carlesso E, Cadringher P, Caironi P, Valenza F, Polli F, et al. Lung stress and strain during mechanical ventilation for acute respiratory distress syndrome. Am J Respir Crit Care Med. 2008;178:346–55. 21. Muscedere JG, Mullen JB, Gan K, Slutsky AS. Tidal ventilation",3,41,0.8187897205352783
8,Does mechanical ventilation with a lower tidal volume result increased ventilator free days with patients with acute lung injury and acute respiratory distress syndrome?,PPATDSHMA.pdf," J Thorac Dis. 2015;7(3):35667. https://doi.org/10.3978/j. issn.2072-1439.2014.12.49. 16. Mora-Arteaga JA, Bernal-Ramirez OJ, Rodriguez SJ. The effects of prone position ventilation in patients with acute respiratory distress syndrome. A systematic review and metaanalysis. Medicina Intensiva. 2015;39(6):35972",8,97,0.8143062591552734
8,Does mechanical ventilation with a lower tidal volume result increased ventilator free days with patients with acute lung injury and acute respiratory distress syndrome?,FMWSCPARDS.pdf,"; critical illness; fluid  therapy; shock Conservative fluid management improves ventilator-free days and oxygenation in patients  with the Acute Respiratory Distress Syndrome (ARDS). In the Fluid and Catheter Treatment  Trial (FACTT) of the National Institutes of Health, National Heart Lung and Blood Institute,  ARDS Network (NIH/NHLBI ARDS Network), patients were randomized and managed  with either a conservative fluid protocol (FACTT Conservative)",2,16,0.8135685920715332
8,Does mechanical ventilation with a lower tidal volume result increased ventilator free days with patients with acute lung injury and acute respiratory distress syndrome?,ETSDMV.pdf," [17,18,22,23]. The main side effects of  dexmedetomidine are bradycardia, hypotension and the potential for withdrawal symptoms  upon discontinuation of long-term therapy [17,18]. When compared to other sedatives,  dexmedetomidine has been shown to result in a more awake and interactive patient, a lower  incidence of delirium, more ventilator free days, and less days in the ICU [17–",3,26,0.8133223056793213
8,Does mechanical ventilation with a lower tidal volume result increased ventilator free days with patients with acute lung injury and acute respiratory distress syndrome?,EDPMARDSLPMV.pdf," positive end-expiratory pressure; PEEPtot,rs: total peep of the respiratory system; pH: potential of hydrogen; Pplat,rs: plateau pressure of the respiratory system; SAPS: simplified acute physiology score; SD: standard deviation; SOFA: sequential organ failure assessment; VILI: ventilator-induced lung injury; VT: tidal volume; ΔPL: transpulmonary driving pressure; ΔPrs: driving pressure of the respiratory system",8,89,0.8128318786621094
9,Prone positioning sessions in patients with severe ARDS significantly decreased mortality?,CEIIUPPSARDS.pdf," cohort study. The Lancet Respiratory Medicine 2017;5(8):627–638. [PubMed:  28624388]  11. Guérin C, Beuret P, Constantin J, et al. A prospective international observational prevalence study  on prone positioning of ARDS patients: the APRONET (ARDS Prone Position Network) study.  Intensive care medicine 2017:1–16. 12. Cooke CR, Kahn JM, Watkins TR, et al",8,75,0.9439983367919922
9,Prone positioning sessions in patients with severe ARDS significantly decreased mortality?,RARDS.pdf," ARDSnet trials showed no difference between patients with moderate–severe and mild–moderate ARDS in terms of mortality, even though there were differences in rapid resolution of ARDS, ventilator-free days, and ICU-free days. Author disclosures are available with the text of this article at www.atsjournals.org. Acknowledgment: The authors are grateful to the investigators of ARDS Network (ARDSNet) trials for collecting the data on which this analysis was based,",3,42,0.8686232566833496
9,Prone positioning sessions in patients with severe ARDS significantly decreased mortality?,ROSE.pdf,"ade (ROSE) trial —  a multicenter, unblinded, randomized trial of  patients with moderate-to-severe ARDS — to  determine the efficacy and safety of early neuro- muscular blockade with concomitant heavy se- dation as compared with a strategy of usual  care with lighter sedation targets. We hypothe- sized that the use of early neuromuscular block- ade would result in lower all-cause in-hospital  mortality at 90 days",2,22,0.8684015274047852
9,Prone positioning sessions in patients with severe ARDS significantly decreased mortality?,NBSARDS.pdf," how NMB agents are used in patients with ARDS. A very high proportion (96.6%) of intensivists who treat patients with moderate to severe ARDS use NMB, and almost 40% of these respondents use NMB in more than half their patients with moderate to severe ARDS. These results are in line with other recent surveys. The LUNG SAFE study, a prospective study of 459 ICUs in 50 countries conducted in the winter of 2014, found that 37",5,59,0.8673136234283447
9,Prone positioning sessions in patients with severe ARDS significantly decreased mortality?,BMIMSARDS.pdf,"Body Mass Index and Mortality in Subjects With ARDS: Post-hoc Analysis of the OSCILLATE Trial Haytham Tlayjeh, Yaseen M Arabi, Niall D Ferguson, Qi Zhou, Francois Lamontagne, Alejandro Arroliga, Valerie Danesh, Guillermo Dominguez-Cherit, Edgar Jimenez, Adam Mullaly, Brandon Staub, and Maureen O Meade; for the Canadian Critical Care Trials Group BACK",1,1,0.8664274215698242
9,Prone positioning sessions in patients with severe ARDS significantly decreased mortality?,CEIIUPPSARDS.pdf, Setting: Intensive care units that care for patients with ARDS. Subjects: Patients with moderate to severe ARDS. For reprints : Corresponding Author: Cameron M Baston. 3400 Spruce St. Philadelphia PA 19104. cbass@alum.mit.edu  +12159133239.  The work was performed at the University of Pennsylvania Declaration of Conflict of Interest: The authors have disclosed that they do not have any conflicts of interest. HHS Public Access Author manuscript Crit,1,6,0.85994553565979
9,Prone positioning sessions in patients with severe ARDS significantly decreased mortality?,EDPMARDSLPMV.pdf," this result may be due to the wide range of VT used across the trials included. To try to answer this question, we investigated ΔPrs from two trials [4, 5] in which strict lung- protective mechanical ventilation, in particular 6 ml/kg predicted body weight VT, was applied to patients with ARDS. Our working hypothesis was that ΔPrs was asso- ciated with death, just like compliance (Crs) or Pplat,rs. Methods This is a",2,18,0.85994553565979
9,Prone positioning sessions in patients with severe ARDS significantly decreased mortality?,APV.pdf," ventilation variables have to be properly adjusted during ventilatory therapy, which generally requires continuous care from clinical staff, es- pecially for patients with severe ARDS. To minimize the workload of daily clinical practice and to maintain the standard protocol of protective ventilation, we introduce automatic control of ventilation as a concept for the treatment. In this article, we describe a strategy of auto- matic ventilation in ARDS patients, including continu- ous monitoring of regional ventilation at thoracic cavity using electrical impedance",2,18,0.8582706451416016
9,Prone positioning sessions in patients with severe ARDS significantly decreased mortality?,ACURASYS.pdf," mechanical ventilation for the acute respiratory distress syn- drome (ARDS), neuromuscular blocking agents may improve oxygenation and de- crease ventilator-induced lung injury but may also cause muscle weakness. We evalu- ated clinical outcomes after 2 days of therapy with neuromuscular blocking agents in  patients with early, severe ARDS. Methods In this multicenter, double-blind trial, 340 patients presenting to the intensive care  unit (ICU) with an onset",1,11,0.8541696071624756
9,Prone positioning sessions in patients with severe ARDS significantly decreased mortality?,LSPA.pdf,"–31 or  high PEEP strategies32,33 that are often employed for management of ARDS. However, deep  sedation is required in patients with ARDS who receive neuromuscular blockage to ensure  patients do not consciously experience paralysis.34,35 Neuromuscular blockage is sometimes  used in severe ARDS based on results of a multicenter trial in France that showed improved  mortality with 48 hours of neuromuscular blockage in patients who have severe",3,23,0.8476228713989258
9,Prone positioning sessions in patients with severe ARDS significantly decreased mortality?,CEIIUPPSARDS.pdf,"entered automatically for patients identified by the electronic health record as being eligible  for PP, then hospitals who admitted few eligible patients should be willing to support it (29). Alternatively, an integrated health system that also insures its beneficiaries might consider  all costs, including additional downstream costs of survivors, making the results of our  societal model more relevant. Suppose such a system was willing to pay $50,000 per QALY  gained and admitted 200 patients with moderate-severe ARDS annually.",6,47,0.8450167179107666
9,Prone positioning sessions in patients with severe ARDS significantly decreased mortality?,TOF-ARDS.pdf,"/kg of predicted body weight  (PBW) [2], a short course of neuromuscular blocking  agents (NMBAs) [3] in severely hypoxemic patients, and  the use of prone positioning (PP) [4]. NMBAs are fre- quently used in the most severe forms of ARDS [1]. They  are the only pharmacologic intervention that has been  shown to improve the prognosis of moderate-to-severe  ARDS",1,12,0.8403716087341309
9,Prone positioning sessions in patients with severe ARDS significantly decreased mortality?,NBSARDS.pdf," original ACURASYS trial13 re- sults in the decision to initiate NMB treatment in ARDS patients. We included 4 identically-worded questions ask- ing the respondents to grade the importance they placed on each of 4 potential justifications for starting NMB in pa- tients with moderate to severe ARDS. Based on a mean weighted score, the most important indication for initiating NMB in patients with moderate to severe ARDS was to allow compliance with ARDSNet mechanical ventilation",5,65,0.8384449481964111
9,Prone positioning sessions in patients with severe ARDS significantly decreased mortality?,ESCNBC.pdf,". Interna- tional studies have confirmed the use of NMBAs in up to  26% of ARDS patients [14]. Yet, conflicting results were  provided by large randomized clinical trials, such as the  ACURASYS [15] and ROSE trials [16], and indication,  efficacy, and safety on the use of NMBAs in such patients  remain uncertain. The severe respiratory failure associated with COVID- 19 has been described as a form of ARDS",2,20,0.8384449481964111
9,Prone positioning sessions in patients with severe ARDS significantly decreased mortality?,FMWSCPARDS.pdf," mortality to FACTT Conservative. FACTT Conservative has improved ventilator-free days,  ICU-free days, and prevalence of acute kidney injury than FACTT Liberal. FACTT Lite can  be used as a simplified and safe alternative to FACTT Conservative for the management of  fluid balance in patients with ARDS. Supplementary Material Refer to Web version on PubMed Central for supplementary material. Acknowledgments Supported, in part, by the National Institutes of Health, National",8,76,0.8290410041809082
9,Prone positioning sessions in patients with severe ARDS significantly decreased mortality?,BMIMSARDS.pdf," THE RELATED EDITORIAL ON PAGE 1173 12 mL/kg did not show any difference in outcome between obese and normal weight subjects.7 Other studies have suggested better survival for obese subjects with ARDS compared to subjects with normal weight.5 Studies have also shown that being underweight is associated with in- creased mortality in subjects with ARDS.8 The Oscillation for ARDS Treated Early (OSCILLATE) study was a randomized, controlled trial that randomized adults with moderate",2,15,0.8264801502227783
9,Prone positioning sessions in patients with severe ARDS significantly decreased mortality?,BMIMSARDS.pdf,". It also includes subjects managed with HFOV, a group in which the relation of BMI and outcomes has not been studied before. Methods Study Subjects and Sample The OSCILLATE trial randomized 548 subjects with moderate-to-severe ARDS to HFOV or conventional ven- tilation from 39 ICUs in Canada, the United States, Saudi Arabia, Chile, and India.9 Institutional review boards of the participating centers approved the study. Patients were eligible for inclusion if they had",2,18,0.8250975608825684
9,Prone positioning sessions in patients with severe ARDS significantly decreased mortality?,BMIMSARDS.pdf," associations at both extremes of BMI. Conclusions In the OSCILLATE Trial, there was no difference in adjusted hospital mortality across all BMI strata in sub- jects with moderate-to-severe ARDS. Processes of care were not different between the BMI strata except for higher daily doses of fentanyl as BMI increased. ACKNOWLEDGMENTS We acknowledge Michael Chasse and Martin Albert for their critical review of the manuscript. REFERENCES 1. Ogden CL,",7,92,0.8250975608825684
10,Does early application of high frequency oscillatory ventilation compared with ventilation strategy of low tidal volume decrease mortality?,OSCILLATE.pdf," other reasons 23 Did not undergo randomization 19 Had Pao2:FIo2 ratio >200 mm Hg  on standard settings 4 Had other reasons Figure 1. Screening, Randomization, and Follow-up. HFOV denotes high-frequency oscillatory ventilation, ICU intensive care unit, and Pao2:Fio2 the ratio of the partial  pressure of arterial oxygen to the fraction of inspired oxygen. The New England Journal of Medicine is produced by NEJM Group",6,81,0.8774561882019043
10,Does early application of high frequency oscillatory ventilation compared with ventilation strategy of low tidal volume decrease mortality?,CEIIUPPSARDS.pdf," assumptions. Keywords Respiratory Distress Syndrome; Adult; Cost-Benefit Analysis; Prone position; Economics;  Hospital; Decision Trees Introduction: Despite recent advances, survival following the acute respiratory distress syndrome (ARDS)  remains 50-60% in many settings (1–4). Prone positioning (PP) in moderate-severe ARDS  has been shown in randomized trials to substantially improve survival, and, like low-tidal- volume ventilation (LTV), is a",2,12,0.8748822212219238
10,Does early application of high frequency oscillatory ventilation compared with ventilation strategy of low tidal volume decrease mortality?,LSPA.pdf,"individual patient data meta-analysis. Intensive care medicine. Jul; 2014 40(7):950–957. [PubMed:  24811940]  30. Kahn JM, Andersson L, Karir V, Polissar NL, Neff MJ, Rubenfeld GD. Low tidal volume  ventilation does not increase sedation use in patients with acute lung injury. Critical care medicine.  Apr; 2005 33(4):766–771. [PubMed",9,85,0.8705143928527832
10,Does early application of high frequency oscillatory ventilation compared with ventilation strategy of low tidal volume decrease mortality?,LSPA.pdf," of Chest Physicians and the American  Thoracic Society recommend using a sedation protocol to minimize sedation of  mechanically ventilated ICU patients.28 Balanced against the recommendation for light sedation is the occasional need for deep  sedation during advanced therapies for severe ARDS. A number of studies have shown that  deep sedation is not required for patients to tolerate the low tidal volume ventilation29–31 or  high PEEP strategies32,33 that are often employed for management of ARDS",3,22,0.8705143928527832
10,Does early application of high frequency oscillatory ventilation compared with ventilation strategy of low tidal volume decrease mortality?,RARDS.pdf," Aerosolized b2-Agonist for Treatment of Acute Lung Injury (ALTA), Initial Trophic vs Full Enteral Feeding in Patients With Acute Lung Injury (EDEN), and Rosuvastatin for Sepsis-Associated Acute Respiratory Distress Syndrome (SAILS) (5–7). For this analysis, we excluded individuals from the Ventilation with Lower Tidal Volumes as Compared with Traditional Tidal Volumes for Acute Lung Injury and",1,6,0.8685815334320068
10,Does early application of high frequency oscillatory ventilation compared with ventilation strategy of low tidal volume decrease mortality?,ARDSNet.pdf,VENTILATION WITH LOWER TIDAL VOLUMES IN PATIENTS WITH THE ACUTE RESPIRATORY DISTRESS SYNDROME Volume 342 Number 18 · 1305 incidence of barotrauma after randomization was sim- ilar in the two groups. There were no significant differences between groups in the percentages of days on which neuro- muscular-blocking drugs were used among patients who were discharged home and breathing without assistance (6±14 percent in the group treated with lower,5,69,0.8685269355773926
10,Does early application of high frequency oscillatory ventilation compared with ventilation strategy of low tidal volume decrease mortality?,CEIIUPPSARDS.pdf," barriers to low tidal volume ventilation with actual practice. Annals of the American  Thoracic Society 2017;14(11):1682–1689. [PubMed: 28771042]  14. Abrams D, Fan E, Ferguson ND, et al. Unproven and Expensive May Still Be Justifiable. American  journal of respiratory and critical care medicine 2018(ja). 15. Sanders GD, Neumann PJ, Basu A, et al. Recommendations for Conduct",8,77,0.8668146133422852
10,Does early application of high frequency oscillatory ventilation compared with ventilation strategy of low tidal volume decrease mortality?,HARDST.pdf,". Intensive Care Med. 1990;16:372–7. 20. Chiumello D, Carlesso E, Cadringher P, Caironi P, Valenza F, Polli F, et al. Lung stress and strain during mechanical ventilation for acute respiratory distress syndrome. Am J Respir Crit Care Med. 2008;178:346–55. 21. Muscedere JG, Mullen JB, Gan K, Slutsky AS. Tidal ventilation",3,41,0.8643131256103516
10,Does early application of high frequency oscillatory ventilation compared with ventilation strategy of low tidal volume decrease mortality?,BMIMSARDS.pdf,"ated Early (OSCILLATE) study was a randomized, controlled trial that randomized adults with moderate-to-severe ARDS to high-frequency oscillatory ventilation (HFOV) or conventional mechani- cal ventilation. The purpose of this sub-analysis of the OSCILLATE trial was to examine the association of BMI on mortality and relevant processes of care of subjects withmoderate-to-severeARDS.Wehypothesizedthatmor- tality differs across different BMI strata and",2,16,0.8521647453308105
10,Does early application of high frequency oscillatory ventilation compared with ventilation strategy of low tidal volume decrease mortality?,ENB.pdf,"OSE trial  specifically mentioned the reason to use fixed  dose was to replicate the dosing regimen used  in the (ACURASYS) trial and to facilitate ad­ herence to the trial protocol.11, 15 All the studies  used lung protective ventilation with low tidal  volume with an aim of keeping plateau pres­ sure ≤30 cm H2O. It is also noted ACURASYS  and ROSE trials used one bolus NMDA per 24  hours in control group",4,52,0.851600170135498
10,Does early application of high frequency oscillatory ventilation compared with ventilation strategy of low tidal volume decrease mortality?,CEIIUPPSARDS.pdf," medicine 2017:1–16. 12. Cooke CR, Kahn JM, Watkins TR, et al. Cost-effectiveness of implementing low-tidal volume  ventilation in patients with acute lung injury. CHEST Journal 2009;136(1):79–88. 13. Weiss CH, Baker DW, Tulas K, et al. A critical care clinician survey comparing attitudes and  perceived barriers to low tidal volume ventilation with actual practice. Annals of the American  Thoracic Society",8,76,0.8417932987213135
10,Does early application of high frequency oscillatory ventilation compared with ventilation strategy of low tidal volume decrease mortality?,ARDSNet.pdf,"Volume 342 Number 18 · 1301 The New England Journal of Medicine © Copyright, 2000, by the Massachusetts Medical Society VOLUME 342 MAY 4, 2000 NUMBER 18 VENTILATION WITH LOWER TIDAL VOLUMES AS COMPARED WITH  TRADITIONAL TIDAL VOLUMES FOR ACUTE LUNG INJURY AND THE ACUTE RESPIRATORY DISTRESS SYNDROME THE ACUTE RESPIRATORY DISTRESS SYNDROME NETWORK",1,1,0.8356211185455322
10,Does early application of high frequency oscillatory ventilation compared with ventilation strategy of low tidal volume decrease mortality?,RARDS.pdf," Thompson BT, Wheeler A; Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000;342:1301–1308. 9 Brower RG, Lanken PN, MacIntyre N, Matthay MA, Morris A, Ancukiewicz M, et al.; National Heart, Lung, and Blood Institute ARDS Clinical Trials Network. Higher",3,52,0.8356211185455322
10,Does early application of high frequency oscillatory ventilation compared with ventilation strategy of low tidal volume decrease mortality?,EDPMARDSLPMV.pdf,"ôpitaux de Marseille Department of Research and Innovation Support Unit for clinical research and economic evaluation, Marseille 13005, France. Received: 17 August 2016 Accepted: 2 November 2016 References 1. ARDSnet. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med. 2000;342(18):1301–8. 2. Amato",8,97,0.8356211185455322
10,Does early application of high frequency oscillatory ventilation compared with ventilation strategy of low tidal volume decrease mortality?,ENB.pdf,≤30  cm H20 AECC: American-European Consensus Conference; ARDS: Acute Respiratory Distress Syndrome; PaO2/FiO2: partial pressure of oxygen/ fractional inspired oxygen; PEEP: positive end expiratory pressure; TOF: train of four; ARDSnet protocol: ventilation with lower tidal  volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome; NO: nitric oxide; ,4,60,0.8355016708374023
10,Does early application of high frequency oscillatory ventilation compared with ventilation strategy of low tidal volume decrease mortality?,HARDST.pdf,"ere JG, Mullen JB, Gan K, Slutsky AS. Tidal ventilation at low airway pressures can augment lung injury. Am J Respir Crit Care Med. 1994;149:1327–34. 22. Caironi P, Cressoni M, Chiumello D, Ranieri M, Quintel M, Russo SG, et al. Lung opening and closing during ventilation of acute respiratory distress syndrome. Am J Respir Crit Care Med. 2010;",3,42,0.8281264305114746
10,Does early application of high frequency oscillatory ventilation compared with ventilation strategy of low tidal volume decrease mortality?,LSPA.pdf,"seizure, alcohol or benzodiazepine withdrawal, or to ensure deep sedation and amnesia (e.g.,  during paralysis). Recent studies have confirmed that the use of benzodiazepines for  sedation in critically ill patients is associated with increased delirium, increased hospital  length of stay, increased time on mechanical ventilation, and increased intensive care unit  hospitalization.2,52–54 A recent propensity-based analysis also suggested that  benzodiazepine use",5,38,0.8226113319396973
10,Does early application of high frequency oscillatory ventilation compared with ventilation strategy of low tidal volume decrease mortality?,DDMLSMVICP.pdf,"EDCOM (Safety and Efﬁcacy of Dexmedetomidine Compared With Midazolam) Study Group D elirium is a recognized organ dysfunction complicating critical illness and consti- tutes a major challenge to in- tensive care practitioners worldwide (1– 3). In a survey of critical care clinicians, 85% of responders perceived intensive care unit (ICU) delirium as a signiﬁcant factor in prolonged ventilation",1,2,0.8213117122650146
10,Does early application of high frequency oscillatory ventilation compared with ventilation strategy of low tidal volume decrease mortality?,PPATDSHMA.pdf," PROSEVA trial, published in 2013. However, the evidence provided by meta-analyses in support of prone ventilation for ARDS was too low to be conclusive. The pres- ent study shows that meta-analysis is indeed not the best approach for the assessment of evi- dence as to the efﬁcacy of prone ventilation. Methods: We performed a cumulative meta-analysis to prove that only the PROSEVA trial, due to its strong protective effect, has",2,5,0.8164489269256592
10,Does early application of high frequency oscillatory ventilation compared with ventilation strategy of low tidal volume decrease mortality?,ETSDMV.pdf," a nonbenzodiazepine  sedative such as dexmedetomidine or propofol should be used if sedation is needed, though  analgesia alone may be adequate. When sedation is administered, a light level of sedation  should be targeted utilizing daily interruptions of sedation or nursing protocols with  validated sedations scales. Avoiding benzodiazepines and deep sedation results in less  delirium, shorter duration of mechanical ventilation, and improved mortality.",6,53,0.8156204223632812
